Koyfin Home > Directory > Health Care > Abbott Laboratories > Issuance of Common Stock

Abbott Laboratories Issuance of Common Stock Chart (ABT)

Abbott Laboratories annual/quarterly Issuance of Common Stock from 2010 to 2020.
  • Abbott Laboratories Issuance of Common Stock for the quarter ending September 09, 2020 was $83m a 91.57% increase of 76m year over year
  • Abbott Laboratories Issuance of Common Stock for the last 12 months ending September 09, 2020 was $236m a -26.27% decrease of -62m year over year
  • Abbott Laboratories Annual Issuance of Common Stock for 2019 was $298m a 9.06% increase of 27m from 2018
  • Abbott Laboratories Annual Issuance of Common Stock for 2018 was $271m a -29.15% decrease of -79m from 2017
  • Abbott Laboratories Annual Issuance of Common Stock for 2017 was $350m a 29.14% increase of 102m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Issuance of Common Stock Data

09/2020$83m
06/2020$57m
03/2020$89m
12/2019$7m
09/2019$47m
06/2019$117m
03/2019$127m
12/2018$27m
09/2018$74m
06/2018$33m

Annual ABT Issuance of Common Stock Data

2019$298m
2018$271m
2017$350m
2016$248m
2015$314m
2014$429m
2013$395m
2012$1,850m
2011$969m
2010$328m